Video
Study shows feasibility of incorporating hereditary cancer risk assessments into community urology practices
Author(s):
“The traction on this, I think, is really rather remarkable,” says Neal D. Shore, MD, FACS.
In this video, Neal D. Shore, MD, FACS, discusses the findings of the study, “Hereditary cancer risk assessment in the community urology practice setting,” which was presented at the 2022 ASCO Genitourinary Cancers Symposium. Shore is the director of the Carolina Urologic Research Center, Atlantic Urology Clinics in Myrtle Beach, South Carolina.
Related Videos
Related Content
